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Near infrared spectroscopy for the assessment of peripheral tissue oxygenation in 
pulmonary arterial hypertension. 
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“take home” message: Near infrared spectroscopy offers a qualitative, noninvasive 
indication of mixed venous oxygen saturation in PAH.
Pulmonary arterial hypertension (PAH) is characterised by increased pulmonary vascular 
resistance and results in increased morbidity and mortality due to right heart failure and a 
progressive decline in cardiac output (CO) [1]. The latter disturbs oxygen delivery to 
periphery and may lead to pathological changes in tissue oxygenation. The balance 
between global oxygen supply and demand is reflected in mixed venous oxygen 
saturation (SvO2), an index that is generally reduced in patients with PAH [2]. SvO2 at 
baseline is one of the strongest predictors of survival in PAH [3-5]; this is also true for 
changes in SvO2 during follow-up [4]. Cut-off values of 60% [6] and 65% [4] have been 
used to distinguish between prognostic groups suggesting that these may be suitable 
treatment goals. SvO2 is measured invasively in the pulmonary artery, where venous 
blood mixes after circulating through the superior and inferior vena cava, coronary 
sinuses and the right-heart chambers. 
Spatially resolved near infrared spectroscopy (NIRS) offers a noninvasive, rapidly 
responsive method for measuring skeletal muscle oxygenation by examining absorption 
differences in the near infrared spectrum of light between oxy- and deoxy- haemoglobin 
and myoglobin molecules in the microvasculature. The tissue oxygenation index (StO2) is 
commonly adopted as an index of the dynamic balance between local tissue oxygen 
supply (availability) and utilization (extraction) in both health and disease [7, 8]. Because 
the contribution of the myoglobin to the NIRS signal is not critical, StO2 is largely 
considered as the ratio of oxygenated to total tissue hemoglobin concentration expressed 
as [oxyhemoglobin/ (oxyhemoglobin + deoxyhemoglobin)] × 100 (%). To evaluate NIRS 
in PAH, we correlated measurement of vastus lateralis StO2 with SvO2 and venous 
oxygen saturation in the inferior vena cava (SivcO2) during right heart catheterisation. 
To measure StO2, one transcutaneous sensor (S-Type Probe; NIRO-200NX spatially 
resolved spectrophotometer, Hamamatsu Photonics KK, Japan) was placed over each 
vastus lateralis muscle, 10-12 cm above the lateral epicondyle. StO2 values shown are the 
average values obtained from both legs at the time of SvO2 and SicvO2 single-point 
measurements. SvO2 was measured from the distal port of the Swan–Ganz catheter. 
Resting SivcO2 was measured with a pigtail catheter advanced through the right internal 
jugular vein sheath to the level of S1 vertebra. 
 
Concurrent, single-point measurements of SvO2 and StO2 were repeated during supine 
exercise in consecutive patients who consented to this task. One patient performed 
straight leg raise and nine patients exercised on an electronically braked lower limb cycle 
ergometer secured to the catheterization table. Subjects cycled at 60 revolutions/min for 6 
minutes at a constant workload set at 50% of peak work rate achieved during an upright 
cycle cardiopulmonary exercise test the previous day. SvO2 and StO2 were measured 
during the sixth minute. Supplementary oxygen was provided as required to maintain 
normoxia. 
Twenty-five subjects with PAH were studied at rest, 10 of whom also exercised. 
The main clinical and physiological characteristics are presented in figure 1. Combining 
all the resting and exercise data points (n=35), StO2 showed a good correlation with 
SvO2 (r=.703, p<.001). This level of correlation persisted when looking separately at rest 
(r=.701, p<.001) and exercise data (r=.863, p=.001) (figure 1) but also for the change 
from rest to exercise in StO2 and SvO2 (r=.669, p=.034). A significant reduction (p<.001) 
was observed in StO2 during exercise. Resting values of StO2 exhibited similar level of 
correlation with SivcO2 (r=.655, p=.001). A good correlation (r=.703, p<.001) was 
observed between SivcO2 and SvO2, whereas the resting correlations of StO2 with SvO2 
and SivcO2 were not statistically different (Z=0.3, p =.76). 
 
Resting StO2 correlated with age (r=-.416, p= .038) but also with indices of disease 
severity including the six-minute walk distance (r=.528, p=.008), N-terminal pro-brain 
natriuretic peptide (r=-.395, p=.05), diffusing lung capacity for carbon monoxide percent 
predicted (r=.398, p=.049). 
 
To our knowledge, this is the first study to report on the association between StO2 and 
SvO2. Good correlation between vastus lateralis StO2 and femoral venous oxygen 
saturation has also been reported in healthy trained subjects [9] albeit earlier studies did 
not confirm such correlation [10, 11]. However, comparisons should be made with 
caution as responses of StO2 depend highly on the mode, intensity and duration of 
exercise and neither of those studies is matched in design to our resting and steady-state 
exercise protocol. Instead, they report on measurements either during incremental 
exercise [9] or over time during constant load exercise [10, 11].  
 
Nonetheless, the correlation between StO2 and SvO2 or SivcO2 is not absolute and results 
of relating StO2 to venous blood oxygenation should not be interpreted in a quantitative 
sense. This may be because the specific tissue volume investigated by NIRS is not fully 
representative of the oxygen status of the body segment (lower limb) or global tissue 
oxygenation as measured by SivcO2 and SvO2, respectively [7]. It is not surprising that 
the highest correlations between StO2 and venous oxygen saturation were shown when 
the sampled venous effluent was specific for the interrogated tissue volume such as that 
obtained from a deep forearm vein that drained the exercising muscle (r=.92) [8] or from 
a vein that drained only the electrically simulated muscle of dogs (r=.97)  [12]. 
Accordingly, SivcO2 would be expected to exhibit a higher correlation with StO2 than 
SvO2. However, we observed similar correlation between StO2 and SvO2. This seeming 
paradox may be due to venous return from the lower limbs being the major determinant 
of  SvO2 in the supine leg exercise.  
The design of the present study does not allow for reliable conclusions on the tissue 
oxygen status per se; the presented measurements should be interpreted within the 
context of oxygen supplementation to maintain resting normoxia and the absence of a 
matched control group. However, our findings provide support for the use of NIRS in the 
investigation of the pathophysiological abnormalities in PAH. Also, taken together, 
findings cannot exclude a role of the periphery in the pathophysiology of PAH since 
skeletal muscle tissue microenvironment, which is an important factor of the local 
oxygen status, is disturbed in PAH [13]. Perhaps, combination of NIRS with other 
techniques such as vascular occlusion, sidestream dark field imaging and histological 
examination could enable further exploration. 
 
Limited experience from application of NIRS in PAH showed significantly lower resting 
thenar muscle oxygen saturation in PAH patients compared with matched healthy 
subjects and patients with CHF [14]. Also, study of the kinetics of the vastus lateralis 
fractional oxygen extraction (% Δ deoxyhemoglobin/myoglobin) relative to oxygen 
uptake at the beginning of heavy-intensity exercise, suggests that patients with PAH have 
greater microvascular oxygen delivery-to-utilization inequalities compared to healthy 
control, which contribute to slow adaptation rate of aerobic metabolism [15]. 
 
In summary, skeletal muscle StO2 in PAH subjects correlated significantly with SvO2 
under both resting and exercise conditions. Also, StO2 correlated significantly, albeit 
weakly, with indices of disease severity. These novel findings suggest that StO2 may 
serve as a clinically useful research tool for the qualitative, noninvasive assessment of the 
dynamic balance between oxygen supply and utilization in PAH. Further studies are 
warranted to explore the value of NIRS in the assessment and prognosis of PAH.
Figure legends 
Figure 1: Patient characteristics and correlations between StO2 and SvO2 at rest (A) and 
during exercise (B).  
 
 
 
Patient                       characteristic Rest             (n=25) Exercise                           (n=10; 
rest/exercise) 
Age, y 61.9 ± 11.6 55.6 ± 8.4 
Sex, males: females 11: 14 4: 6 
IPAH; FPAH;               C TD; 
CHD; PoPH 
13;1;7;1;3 4;1;3;1;1 
6MWT, m 256 ± 134 344 ± 144 
NTproBNP, pg/ml 1101  
(153, 2928) 
263  
(42, 1461) 
mean PAP, mm Hg 43 ± 11 40.7 ± 10.2/66.1 ± 13.8* 
CO, L/min 4.6 ± 1.7 5.5 ± 1.96/8.6 ± 3.3* 
PVR, Wood units 9.5 ± 5.9 7.3 ± 4.3/7.9 ± 4.5 
SvO2, % 62.5 ± 12.9 70.3 ± 8.6/42.3 ± 16.6* 
SivcO2, % 64.2 ± 14.3 N/A 
StO2, % 73.1 ± 9.8 77.62 ± 6.9/69.2 ± 9.2*  
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